Simplex Trading
BMY icon

Simplex Trading’s Bristol-Myers Squibb BMY Stock Holding History

Simplex Trading’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.8M Sell
705,900
-258,600
-27% -$15.1M 0.03% 255
2025
Q4 		$52M Sell
964,500
-421,600
-30% -$20.3M 0.03% 281
2025
Q3 		$62.5M Buy
1,386,100
+521,800
+60% +$24.4M 0.03% 295
2025
Q2 		$40M Sell
864,300
-105,900
-11% -$5.2M 0.02% 337
2025
Q1 		$59.2M Sell
970,200
-639,900
-40% -$37.3M 0.04% 233
2024
Q4 		$91.1M Sell
1,610,100
-657,000
-29% -$36.7M 0.05% 180
2024
Q3 		$117M Buy
2,267,100
+690,200
+44% +$32.4M 0.07% 135
2024
Q2 		$65.5M Buy
1,576,900
+132,600
+9% +$5.93M 0.04% 250
2024
Q1 		$78.3M Sell
1,444,300
-172,600
-11% -$8.79M 0.05% 226
2023
Q4 		$83M Buy
1,616,900
+498,600
+45% +$26.2M 0.05% 214
2023
Q3 		$64.9M Buy
1,118,300
+294,100
+36% +$18M 0.05% 219
2023
Q2 		$52.7M Sell
824,200
-130,400
-14% -$8.74M 0.04% 258
2023
Q1 		$66.2M Sell
954,600
-142,600
-13% -$10.1M 0.06% 230
2022
Q4 		$78.9M Buy
1,097,200
+220,400
+25% +$16.6M 0.09% 187
2022
Q3 		$62.3M Buy
876,800
+155,100
+21% +$11.3M 0.07% 195
2022
Q2 		$55.6M Sell
721,700
-599,600
-45% -$45.7M 0.06% 219
2022
Q1 		$96.5M Buy
1,321,300
+144,100
+12% +$9.68M 0.09% 157
2021
Q4 		$73.4M Buy
1,177,200
+478,500
+68% +$28.1M 0.07% 204
2021
Q3 		$46.5M Sell
698,700
-4,900
-0.7% -$323K 0.04% 259
2021
Q2 		$47M Buy
703,600
+698,934
+14,979% +$45.6M 0.05% 250
2021
Q1 		$29.5M Buy
4,666
+262
+6% +$16.3K 0.05% 218
2020
Q4 		$27.3M Sell
4,404
-2,292
-34% -$141K 0.04% 281
2020
Q3 		$39.8M Sell
6,696
-1,991
-23% -$120K 0.05% 195
2020
Q2 		$50.5M Sell
8,687
-2,267
-21% -$136K 0.08% 140
2020
Q1 		$60.6M Buy
10,954
+1,532
+16% +$93.6K 0.11% 89
2019
Q4 		$516K Buy
9,422
+2,719
+41% +$156K ﹤0.01% 2724
2019
Q3 		$34M Sell
6,703
-398
-6% -$18.7K 0.1% 136
2019
Q2 		$32.2M Sell
7,101
-3,701
-34% -$172K 0.09% 141
2019
Q1 		$51.5M Buy
10,802
+6,348
+143% +$316K 0.14% 90
2018
Q4 		$23.2M Buy
4,454
+1,747
+65% +$93.9K 0.07% 173
2018
Q3 		$16.8M Sell
2,707
-1,315
-33% -$78K 0.05% 235
2018
Q2 		$22.3M Sell
4,022
-220
-5% -$11.9K 0.09% 159
2018
Q1 		$781K Buy
4,242
+771
+22% +$49.6K 0.03% 494
2017
Q4 		$1.23M Sell
3,471
-1,074
-24% -$67.2K 0.05% 323
2017
Q3 		$2.52M Sell
4,545
-1,113
-20% -$65K 0.1% 149
2017
Q2 		$1.13M Sell
5,658
-1,922
-25% -$105K 0.05% 321
2017
Q1 		$1.27M Buy
7,580
+1,180
+18% +$64.7K 0.06% 310
2016
Q4 		$1.53M Buy
6,400
+3,149
+97% +$172K 0.09% 172
2016
Q3 		$223K Sell
3,251
-321
-9% -$20.6K 0.02% 951
2016
Q2 		$908K Buy
3,572
+2,148
+151% +$152K 0.06% 304
2016
Q1 		$265K Buy
1,424
+91
+7% +$5.74K 0.02% 717
2015
Q4 		$531K Sell
1,333
-2,054
-61% -$136K 0.04% 409
2015
Q3 		$473K Buy
3,387
+2,353
+228% +$149K 0.03% 466
2015
Q2 		$235K Sell
1,034
-127
-11% -$8.37K 0.02% 719
2015
Q1 		$303K Buy
1,161
+460
+66% +$28.8K 0.04% 526
2014
Q4 		$61K Buy
+701
New +$39.5K 0.01% 1228

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplex Trading's BMY Position: Q4 2025 in Review

Simplex Trading sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 256,777 shares — an estimated $12.4M sold.

Simplex Trading first reported a position in BMY in Q1 2015 and held it in 33 quarters. The position peaked at $27.3M in Q1 2024. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • Simplex Trading reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 256,777 Bristol-Myers Squibb shares in Q4 2025, an estimated $12.4M.
  • Simplex Trading first reported a position in Bristol-Myers Squibb in Q1 2015 and held it in 33 quarters.
  • Simplex Trading's Bristol-Myers Squibb position peaked at $27.3M in Q1 2024.
  • 2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.